BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sivertsson L, Synnergren J, Jensen J, Björquist P, Ingelman-Sundberg M. Hepatic differentiation and maturation of human embryonic stem cells cultured in a perfused three-dimensional bioreactor. Stem Cells Dev 2013;22:581-94. [PMID: 22970843 DOI: 10.1089/scd.2012.0202] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 4.1] [Reference Citation Analysis]
Number Citing Articles
1 Cipriano M, Freyer N, Knöspel F, Oliveira NG, Barcia R, Cruz PE, Cruz H, Castro M, Santos JM, Zeilinger K, Miranda JP. Self-assembled 3D spheroids and hollow-fibre bioreactors improve MSC-derived hepatocyte-like cell maturation in vitro. Arch Toxicol 2017;91:1815-32. [PMID: 27590069 DOI: 10.1007/s00204-016-1838-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
2 Obregón R, Ramón-azcón J, Ahadian S. Bioreactors in Tissue Engineering. In: Hasan A, editor. Tissue Engineering for Artificial Organs. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA; 2017. pp. 169-213. [DOI: 10.1002/9783527689934.ch6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
3 Ogawa S, Surapisitchat J, Virtanen C, Ogawa M, Niapour M, Sugamori KS, Wang S, Tamblyn L, Guillemette C, Hoffmann E, Zhao B, Strom S, Laposa RR, Tyndale RF, Grant DM, Keller G. Three-dimensional culture and camp signaling promote the maturation of human pluripotent stem cell-derived hepatocytes. Development. 2013;140:3285-3296. [PMID: 23861064 DOI: 10.1242/dev.090266] [Cited by in Crossref: 105] [Cited by in F6Publishing: 95] [Article Influence: 11.7] [Reference Citation Analysis]
4 Hussein KH, Park K, Kang K, Woo H. Heparin-gelatin mixture improves vascular reconstruction efficiency and hepatic function in bioengineered livers. Acta Biomaterialia 2016;38:82-93. [DOI: 10.1016/j.actbio.2016.04.042] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 8.3] [Reference Citation Analysis]
5 Sjogren AK, Liljevald M, Glinghammar B, Sagemark J, Li XQ, Jonebring A, Cotgreave I, Brolén G, Andersson TB. Critical differences in toxicity mechanisms in induced pluripotent stem cell-derived hepatocytes, hepatic cell lines and primary hepatocytes. Arch Toxicol 2014;88:1427-37. [PMID: 24912781 DOI: 10.1007/s00204-014-1265-z] [Cited by in Crossref: 60] [Cited by in F6Publishing: 49] [Article Influence: 7.5] [Reference Citation Analysis]
6 Ajiteru O, Choi KY, Lim TH, Kim DY, Hong H, Lee YJ, Lee JS, Lee H, Suh YJ, Sultan MT, Lee OJ, Kim SH, Park CH. A digital light processing 3D printed magnetic bioreactor system using silk magnetic bioink. Biofabrication 2021;13. [PMID: 33887719 DOI: 10.1088/1758-5090/abfaee] [Reference Citation Analysis]
7 Toivonen S, Malinen MM, Küblbeck J, Petsalo A, Urtti A, Honkakoski P, Otonkoski T. Regulation of Human Pluripotent Stem Cell-Derived Hepatic Cell Phenotype by Three-Dimensional Hydrogel Models. Tissue Eng Part A 2016;22:971-84. [PMID: 27329070 DOI: 10.1089/ten.TEA.2016.0127] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
8 Tasnim F, Toh Y, Qu Y, Li H, Phan D, Narmada BC, Ananthanarayanan A, Mittal N, Meng RQ, Yu H. Functionally Enhanced Human Stem Cell Derived Hepatocytes in Galactosylated Cellulosic Sponges for Hepatotoxicity Testing. Mol Pharmaceutics 2016;13:1947-57. [DOI: 10.1021/acs.molpharmaceut.6b00119] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
9 Pettinato G, Ramanathan R, Fisher RA, Mangino MJ, Zhang N, Wen X. Scalable Differentiation of Human iPSCs in a Multicellular Spheroid-based 3D Culture into Hepatocyte-like Cells through Direct Wnt/β-catenin Pathway Inhibition. Sci Rep 2016;6:32888. [PMID: 27616299 DOI: 10.1038/srep32888] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
10 Starokozhko V, Hemmingsen M, Larsen L, Mohanty S, Merema M, Pimentel RC, Wolff A, Emnéus J, Aspegren A, Groothuis G, Dufva M. Differentiation of human-induced pluripotent stem cell under flow conditions to mature hepatocytes for liver tissue engineering. J Tissue Eng Regen Med 2018;12:1273-84. [PMID: 29499107 DOI: 10.1002/term.2659] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
11 Kim JH, Jang YJ, An SY, Son J, Lee J, Lee G, Park JY, Park H, Hwang D, Kim J, Han J. Enhanced Metabolizing Activity of Human ES Cell-Derived Hepatocytes Using a 3D Culture System with Repeated Exposures to Xenobiotics. Toxicol Sci 2015;147:190-206. [DOI: 10.1093/toxsci/kfv121] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
12 Damania A, Jain E, Kumar A. Advancements in in vitro hepatic models: application for drug screening and therapeutics. Hepatol Int 2014;8:23-38. [DOI: 10.1007/s12072-013-9490-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
13 Synnergren J, Drowley L, Plowright AT, Brolén G, Goumans MJ, Gittenberger-de Groot AC, Sartipy P, Wang QD. Comparative transcriptomic analysis identifies genes differentially expressed in human epicardial progenitors and hiPSC-derived cardiac progenitors. Physiol Genomics 2016;48:771-84. [PMID: 27591124 DOI: 10.1152/physiolgenomics.00064.2016] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
14 Yen MH, Wu YY, Liu YS, Rimando M, Ho JH, Lee OK. Efficient generation of hepatic cells from mesenchymal stromal cells by an innovative bio-microfluidic cell culture device. Stem Cell Res Ther 2016;7:120. [PMID: 27542358 DOI: 10.1186/s13287-016-0371-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
15 Galetin A. Rationalizing underprediction of drug clearance from enzyme and transporter kinetic data: from in vitro tools to mechanistic modeling. Methods Mol Biol 2014;1113:255-88. [PMID: 24523117 DOI: 10.1007/978-1-62703-758-7_13] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
16 Li Z, Wu J, Wang L, Han W, Yu J, Liu X, Wang Y, Zhang Y, Feng G, Li W, Stacey GN, Gu Q, Hu B, Wang L, Zhou Q, Hao J. Generation of qualified clinical-grade functional hepatocytes from human embryonic stem cells in chemically defined conditions. Cell Death Dis 2019;10:763. [PMID: 31601782 DOI: 10.1038/s41419-019-1967-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
17 Stacey GN, Coecke S, Price A, Healy L, Jennings P, Wilmes A, Pinset C, Ingelman-sundberg M, Louisse J, Haupt S, Kidd D, Robitski A, Jahnke H, Lemaitre G, Myatt G. Ensuring the Quality of Stem Cell-Derived In Vitro Models for Toxicity Testing. In: Eskes C, Whelan M, editors. Validation of Alternative Methods for Toxicity Testing. Cham: Springer International Publishing; 2016. pp. 259-97. [DOI: 10.1007/978-3-319-33826-2_11] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
18 Zeilinger K, Freyer N, Damm G, Seehofer D, Knöspel F. Cell sources for in vitro human liver cell culture models. Exp Biol Med (Maywood) 2016;241:1684-98. [PMID: 27385595 DOI: 10.1177/1535370216657448] [Cited by in Crossref: 74] [Cited by in F6Publishing: 76] [Article Influence: 12.3] [Reference Citation Analysis]
19 Krueger W, Boelsterli UA, Rasmussen TP. Stem Cell Strategies to Evaluate Idiosyncratic Drug-induced Liver Injury. J Clin Transl Hepatol. 2014;2:143-152. [PMID: 26355943 DOI: 10.14218/jcth.2014.00012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
20 Holmgren G, Ghosheh N, Zeng X, Bogestål Y, Sartipy P, Synnergren J. Identification of stable reference genes in differentiating human pluripotent stem cells. Physiol Genomics 2015;47:232-9. [PMID: 25852171 DOI: 10.1152/physiolgenomics.00130.2014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
21 Herencia C, Almadén Y, Martínez-Moreno JM, Espejo I, Herrera C, Pérez-Sánchez C, Guerrero F, Ciria R, Briceño FJ, Ferrín G, de la Mata M, Muñoz-Castañeda JR. Human mesenchymal stromal cell lysates as a novel strategy to recover liver function. Regen Med 2015;10:25-38. [PMID: 25562350 DOI: 10.2217/rme.14.59] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
22 Meier F, Freyer N, Brzeszczynska J, Knöspel F, Armstrong L, Lako M, Greuel S, Damm G, Ludwig-Schwellinger E, Deschl U, Ross JA, Beilmann M, Zeilinger K. Hepatic differentiation of human iPSCs in different 3D models: A comparative study. Int J Mol Med 2017;40:1759-71. [PMID: 29039463 DOI: 10.3892/ijmm.2017.3190] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
23 Raasch M, Fritsche E, Kurtz A, Bauer M, Mosig AS. Microphysiological systems meet hiPSC technology - New tools for disease modeling of liver infections in basic research and drug development. Adv Drug Deliv Rev 2019;140:51-67. [PMID: 29908880 DOI: 10.1016/j.addr.2018.06.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
24 den Braver-sewradj SP, den Braver MW, Vermeulen NP, Commandeur JN, Richert L, Vos JC. Inter-donor variability of phase I/phase II metabolism of three reference drugs in cryopreserved primary human hepatocytes in suspension and monolayer. Toxicology in Vitro 2016;33:71-9. [DOI: 10.1016/j.tiv.2016.02.013] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
25 Isidro IA, Vicente P, Pais DAM, Almeida JI, Domingues M, Abecasis B, Zapata-Linares N, Rodriguez-Madoz JR, Prosper F, Aspegren A, Alves PM, Serra M. Online monitoring of hiPSC expansion and hepatic differentiation in 3D culture by dielectric spectroscopy. Biotechnol Bioeng 2021;118:3610-7. [PMID: 33713416 DOI: 10.1002/bit.27751] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Lauschke VM, Hendriks DFG, Bell CC, Andersson TB, Ingelman-sundberg M. Novel 3D Culture Systems for Studies of Human Liver Function and Assessments of the Hepatotoxicity of Drugs and Drug Candidates. Chem Res Toxicol 2016;29:1936-55. [DOI: 10.1021/acs.chemrestox.6b00150] [Cited by in Crossref: 141] [Cited by in F6Publishing: 123] [Article Influence: 23.5] [Reference Citation Analysis]
27 Bhatia SN, Underhill GH, Zaret KS, Fox IJ. Cell and tissue engineering for liver disease. Sci Transl Med. 2014;6:245sr2. [PMID: 25031271 DOI: 10.1126/scitranslmed.3005975] [Cited by in Crossref: 178] [Cited by in F6Publishing: 167] [Article Influence: 25.4] [Reference Citation Analysis]
28 Tricot T, Verfaillie CM, Kumar M. Current Status and Challenges of Human Induced Pluripotent Stem Cell-Derived Liver Models in Drug Discovery. Cells 2022;11:442. [DOI: 10.3390/cells11030442] [Reference Citation Analysis]
29 Alépée N, Bahinski A, Daneshian M, De Wever B, Fritsche E, Goldberg A, Hansmann J, Hartung T, Haycock J, Hogberg H, Hoelting L, Kelm JM, Kadereit S, McVey E, Landsiedel R, Leist M, Lübberstedt M, Noor F, Pellevoisin C, Petersohn D, Pfannenbecker U, Reisinger K, Ramirez T, Rothen-Rutishauser B, Schäfer-Korting M, Zeilinger K, Zurich MG. State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology. ALTEX 2014;31:441-77. [PMID: 25027500 DOI: 10.14573/altex.1406111] [Cited by in Crossref: 12] [Cited by in F6Publishing: 62] [Article Influence: 1.5] [Reference Citation Analysis]
30 Handa K, Matsubara K, Fukumitsu K, Guzman-Lepe J, Watson A, Soto-Gutierrez A. Assembly of human organs from stem cells to study liver disease. Am J Pathol 2014;184:348-57. [PMID: 24333262 DOI: 10.1016/j.ajpath.2013.11.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
31 Jenkins MJ, Farid SS. Human pluripotent stem cell-derived products: advances towards robust, scalable and cost-effective manufacturing strategies. Biotechnol J 2015;10:83-95. [PMID: 25524780 DOI: 10.1002/biot.201400348] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 7.8] [Reference Citation Analysis]
32 Carpentier A, Tesfaye A, Chu V, Nimgaonkar I, Zhang F, Lee SB, Thorgeirsson SS, Feinstone SM, Liang TJ. Engrafted human stem cell-derived hepatocytes establish an infectious HCV murine model. J Clin Invest. 2014;124:4953-4964. [PMID: 25295540 DOI: 10.1172/jci75456] [Cited by in Crossref: 104] [Cited by in F6Publishing: 66] [Article Influence: 13.0] [Reference Citation Analysis]
33 Hu C, Li L. In vitro culture of isolated primary hepatocytes and stem cell-derived hepatocyte-like cells for liver regeneration. Protein Cell. 2015;6:562-574. [PMID: 26088193 DOI: 10.1007/s13238-015-0180-2] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 7.0] [Reference Citation Analysis]
34 Zhang S, Zhang Y, Chen L, Liu T, Li Y, Wang Y, Geng Y. Efficient large-scale generation of functional hepatocytes from mouse embryonic stem cells grown in a rotating bioreactor with exogenous growth factors and hormones. Stem Cell Res Ther. 2013;4:145. [PMID: 24294908 DOI: 10.1186/scrt356] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
35 Alépée N, Bahinski A, Daneshian M, De Wever B, Fritsche E, Goldberg A, Hansmann J, Hartung T, Haycock J, Hogberg H, Hoelting L, Kelm JM, Kadereit S, McVey E, Landsiedel R, Leist M, Lübberstedt M, Noor F, Pellevoisin C, Petersohn D, Pfannenbecker U, Reisinger K, Ramirez T, Rothen-Rutishauser B, Schäfer-Korting M, Zeilinger K, Zurich MG. State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology. ALTEX 2014;31:441-77. [PMID: 25027500 DOI: 10.14573/altex.1406111] [Cited by in Crossref: 98] [Cited by in F6Publishing: 46] [Article Influence: 12.3] [Reference Citation Analysis]
36 Ulvestad M, Nordell P, Asplund A, Rehnström M, Jacobsson S, Holmgren G, Davidson L, Brolén G, Edsbagge J, Björquist P, Küppers-Munther B, Andersson TB. Drug metabolizing enzyme and transporter protein profiles of hepatocytes derived from human embryonic and induced pluripotent stem cells. Biochem Pharmacol 2013;86:691-702. [PMID: 23856292 DOI: 10.1016/j.bcp.2013.06.029] [Cited by in Crossref: 75] [Cited by in F6Publishing: 64] [Article Influence: 8.3] [Reference Citation Analysis]
37 Shinde V, Klima S, Sureshkumar PS, Meganathan K, Jagtap S, Rempel E, Rahnenführer J, Hengstler JG, Waldmann T, Hescheler J, Leist M, Sachinidis A. Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation. J Vis Exp 2015;:e52333. [PMID: 26132533 DOI: 10.3791/52333] [Cited by in Crossref: 14] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
38 Yang D, Wang ZQ, Deng JQ, Liao JY, Wang X, Xie J, Deng MM, Lü MH. Adipose-derived stem cells: A candidate for liver regeneration. J Dig Dis 2015;16:489-98. [PMID: 26121206 DOI: 10.1111/1751-2980.12268] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
39 Villarin BL, Cameron K, Szkolnicka D, Rashidi H, Bates N, Kimber SJ, Flint O, Forbes SJ, Iredale JP, Bradley M, Hay DC. Polymer Supported Directed Differentiation Reveals a Unique Gene Signature Predicting Stable Hepatocyte Performance. Adv Healthc Mater 2015;4:1820-5. [PMID: 26109270 DOI: 10.1002/adhm.201500391] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
40 Gómez-Lechón MJ, Tolosa L. Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening. Arch Toxicol. 2016;90:2049-2061. [PMID: 27325232 DOI: 10.1007/s00204-016-1756-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
41 Aravalli RN, Steer CJ. Utility of Common Marmoset (Callithrix jacchus) Embryonic Stem Cells in Liver Disease Modeling, Tissue Engineering and Drug Metabolism. Genes (Basel) 2020;11:E729. [PMID: 32630053 DOI: 10.3390/genes11070729] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
42 Zakikhan K, Pournasr B, Vosough M, Nassiri-Asl M. In Vitro Generated Hepatocyte-Like Cells: A Novel Tool in Regenerative Medicine and Drug Discovery. Cell J 2017;19:204-17. [PMID: 28670513 DOI: 10.22074/cellj.2016.4362] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
43 Suter-Dick L, Alves PM, Blaauboer BJ, Bremm KD, Brito C, Coecke S, Flick B, Fowler P, Hescheler J, Ingelman-Sundberg M, Jennings P, Kelm JM, Manou I, Mistry P, Moretto A, Roth A, Stedman D, van de Water B, Beilmann M. Stem cell-derived systems in toxicology assessment. Stem Cells Dev 2015;24:1284-96. [PMID: 25675366 DOI: 10.1089/scd.2014.0540] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]